History
  • No items yet
midpage
Geisinger v. Piedmont Pathology Associates, Inc.
5:14-cv-00121
| W.D.N.C. | Aug 24, 2017
|
Check Treatment
|
Docket
Case Information

*1 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF NORTH CAROLINA STATESVILLE DIVISION CASE NO. 5:14-cv-00121-RLV-DCK KIM R. GEISINGER, MD, as relator on behalf )

of the United States of America )

) Plaintiff-Relator, ) ) ORDER vs. ) ) PIEDMONT PATHOLOGY ASSOCIATES, )

INC. and PIEDMONT PATHOLOGY, PC, )

) Defendants. ) )

THIS MATTER IS BEFORE THE COURT on the parties Joint Motion to Dismiss (Doc. 31) following the United States’ intervention in this matter. Upon due consideration of the record in this matter, including the Stipulation of Dismissal, this Court finds that the parties have reached a settlement of claims in this matter. ( See Doc. 30-1 (“Settlement Agreement”). Pursuant to the Settlement Agreement the United States and Plaintiff/Relator Kim R. Geisinger have released claims for the “Covered Conduct” as described in Paragraph D of the Settlement Agreement (Doc. 30-1 at 2) and Relator, with the consent of the United States, has released all other claims raised in this Action.

IT IS, THEREFORE, ORDERED THAT : (1) Consistent with the terms of the Settlement Agreement among the United States, Plaintiff/Relator Kim R. Geisinger, and Defendants Piedmont Pathology Associates, Inc. and Piedmont Pathology, PC, all claims asserted by the United States and Plaintiff/Relator in this case for the Covered Conduct as described in Paragraph D of the Settlement Agreement are DISMISSED WITH PREJUDICE ;

(2) Any remaining claims asserted in this Action shall be DISMISSED WITH PREJUDICE as brought by Plaintiff/Relator and DISMISSED WITHOUT PREJUDICE as to the United States; and

(3) This Court shall retain jurisdiction to enforce the terms, conditions, and releases of the Settlement Agreement to the extent reasonable, necessary, and appropriate. This Court further retains jurisdiction to resolve issues relating to Plaintiff/Relator’s claim for attorneys’ fees, expenses, and costs against Defendants under 31 U.S.C § 3730(d). ( See Doc. 30-1 at 4-5). Plaintiff/Rel at or shall have up to and including October 24, 2017 to file either a status report detailing its negotiations with Defendants regarding attorneys’ fees or a motion and supporting memorandum addressing the issue of attorneys’ fees.

SO ORDERED.

Signed: August 24, 2017

Case Details

Case Name: Geisinger v. Piedmont Pathology Associates, Inc.
Court Name: District Court, W.D. North Carolina
Date Published: Aug 24, 2017
Docket Number: 5:14-cv-00121
Court Abbreviation: W.D.N.C.
AI-generated responses must be verified and are not legal advice.
Your Notebook is empty. To add cases, bookmark them from your search, or select Add Cases to extract citations from a PDF or a block of text.